Management of a coughing patient
- Authors: Klyachkina I.L.1
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- Issue: Vol 28, No 5 (2021)
- Pages: 32-42
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313141
- DOI: https://doi.org/10.18565/pharmateca.2021.5.32-42
- ID: 313141
Cite item
Abstract
The article deals with the problem of management of a coughing patient. A large number of causes (various conditions and forms) of cough are known, therefore, special attention is paid to the need for a detailed study of the cough characteristics, which enables deliberate approach to the therapy. The algorithm for management of a coughing patient helps to decide on pharmacological - etiotropic, symptomatic - therapy or non-pharmacological treatment. Information is provided on the effective treatment of cough using a fixed combination of medications - bromhexine+guaifenesin+salbutamol (Ascoril expectorant).
Full Text
About the authors
Irina L. Klyachkina
Russian Medical Academy of Continuous Professional Education
Email: formozailk2012@yandex.ru
Cand. Sci. (Med.), Associate Professor at the Department of Pulmonology Moscow, Russia
References
- Morice A.H., Mihqvist E., Bieksiene K., et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55:1901136. doi: 10.1183/13993003.01136-2019.
- Чучалин А.Е, Абросимов В.Н. Кашель. 2-е изд., перераб. и допол. М., 2012. 128 с.
- Шварц Л. С. Кашель. Большая Медицинская Энциклопедия. 2-е изд. Том 12, столбцы 539-514. М., 1959
- Brooks S.M. Perspective on the human cough reflex. Cough. 2011;7:10. doi: 10.1186/17459974-7-10.
- Morice A.H. Epidemiology of cough. Pulm Pharmacol Ther. 2002;15(3):253-59. doi: 10.1006/pupt.2002.0352.
- Irwin R.S., et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the ACCP Chest. 1998;2:133S-181S. doi: 10.1378/chest.114.2_supplement.133s.
- O'Connell F., Thomas V.E., Studham J.M., et al. Capsaicin cough sensitivity increases during upper respiratory infection. Respir Med. 1996;90:279-286. doi: 10.1016/s0954-6111(96)90099-2.
- Dicpinigaitis P.V., Bhat R., Rhoton W.A., et al. Effect of viral upper respiratory tract infection on the urge-to-cough sensation. Respir Med. 2011;105:615-18. Doi: 10.1016/j. rmed.2010.12.002.
- Morice A.H., Millqvist E., Belvisi M.G., et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014;44:1132-doi: 10.1183/09031936.00218613.
- Клячкина И.Л. Кашель у женщин. Фарматека. 2019;5:127-132
- Синопальников А.И., Клячкина И.Л. Кашель: дифференциальная диагностика и дифференцированное лечение. Терапевтический архив. 2012;8:95-102
- Irwin R.S., Madison J.M. The diagnosis and treatment of cough. N Engl J Med. 2000;343:1715-21. Doi: 10.1056/ NEJM200012073432308.
- Moris A.H., Kastelik J.A. Cough 1: Chronic cough in adults. Review series. Thorax. 2003;58:901-7. doi: 10.1136/thorax.58.10.901.
- Irwin R.S., French C.L., Chang A.B., Altman K.W. Classification of Cough as a Symptom in Adults and Management Algorithms. CHEST Guideline and Expert Panel Report. Chest. 2018;153(1):196-209. doi: 10.1016/j.chest.2017.10.016.
- Morice A.H. Cough and sputum. In: ERS Handbook Respiratory Medicine. Editors Palange P., Simonds A. UK: Latimer Trend&Co. Ltd, 2010, P 23-29, 54.
- Eccles R., Fietze I., Rose U-W. Rationale for Treatment of Common Cold and Flu with Multi-Ingredient Combination Products for Multi-Symptom Relief in Adults. Open J Respir Dis. 2014;24:73-8.
- Kardos R Management of cough in adults. Breathe. 2010;2:123-133.
- Вотчал Б.Е. Очерки клинической фармакологии. М.,1965. С. 428-33. [Votchal B.E. Essays on Clinical Pharmacology. M., 1965. R 428-33. (In Russ.)].
- Dicpinigaitis R.V., Morice A.H., Birring S.S., et al. Antitussive Drugs - Rast, Present, and Future. Pharmacol Rev. 2014;66(2):468-512. doi: 10.1124/pr.111.005116.
- Rogers D.F. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care. 2007;52(9):1176-93.
- Balsamo R., Lanata L., Egan C.G. Mucoactive drugs. Eur Respir Rev. 2010;19(116):127-33. doi: 10.1183/09059180.00003510.
- Клячкина И.Л., Синопальников А.И. Мукоактивные препараты. В кн.: Рациональная фармакотерапия заболеваний органов дыхания. Под ред. Чучалина А.Г Руководство для практикующих врачей. 2-е изд., исправ. и допол. М., 2013. С. 103-17
- Chung K.F., Canning B., McGarvey L. Eight International London Cough Symposium 2014: Cough hypersensitivity syndrome as the basis for chronic cough. Pulm Pharmacol Ther. 2015;35:76-80. Doi: 10.1016/j. pupt.2015.08.009.
- Mazzone S.B., Chung K.F., McGarvey L. The heterogeneity of chronic cough: a case for endotypes of cough hypersensitivity. Lancet Respir Med. 2018;6:636-46. doi: 10.1016/S2213-2600(18)30150-4.
- Dicpinigaitis P.V., Gayle Y.E. Effect of Guaifenesin on Cough Reflex Sensitivity. CHEST 2003;124:2178-2181. doi: 10.1378/ chest.124.6.2178.
- Morice A.H., Kantar A., Dicpinigaitis P.V., et al. Treating acute cough: wet versus dry - have we got the paradigm wrong? ERJ Open Res. 2015;1(2):00055-2015. doi: 10.1183/23120541.00055-2015.
- Jayaram S., Desai A. Efficacy, and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients - a randomised doubleblind comparative trial. J Indian Med Assoc. 2000;98:68-70.
- Ainapure S.S., Desai A., Korde K. Efficacy and safety of Ascoril in the management of cough -National Study Group report. J Indian Med Assoc. 2001;99:111, 114.
- Федосеев Г.Б., Орлова Н.Ю., Шалюга Л.В. Применение препарата «АСКОРИЛ» в амбулаторной практике. Новые Санкт-Петербургские врачебные ведомости. 2002;1(19): 69-70.
- Федосеев Г.Б., Зинакова М.К., Ровкина Е.И., Щукина Т.В. Клинические аспекты применении аскорила в пульмонологической клинике. Новые Санкт-Петербургские врачебные ведомости. 2002;2(20):64-67
- Корж А.Н., Краснокутский С.В., Васькив Н.Н. Применение препарата «Аскорил» в лечении больных хроническим обструктивным заболеванием легких. Consilium medicum Ukraina. 2007;1(4):15-17
- Клячкина И.Л. Лечение кашля при острых респираторных вирусных инфекциях у пациентов группы риска. ВМЖ. 2009;7:40-45
- Клячкина И.Л., Дмитриев Ю.К. Лечение нетяжелых обострений хрнонической обструктивной болезни легких. Клиническая медицина. 2012;3:69-73
- Prabhu Shankar S., Chandrashekharan S., Bolmall C.S., Baliga V. Efficacy, safety and tolerability of salbutamol+guaiphenesin+bromh exine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study. J Indian Med Assoc. 2010;108:313-14, 316-18, 320
- Григорьева Н.Ю. Оценка клинической эффективности и безопасности комбинированного препарата Аскорил у больных c коморбидной бронхолегочной и сердечно-сосудистой патологией. Русский медицинский журнал. 2013;29:1475-79
- Клячкина И.Л. Хронический бронхит: фармакотерапевтический фокус на гиперсенситивный компонент кашля. Consilium Medicum. 2020;22(3):46-54